Skip to content Skip to footer
Subscribe Now

TOP 20

Biopharma Deal Terminations Top 20 2018 - 19
Top Biopharma Deal Terminations of 2018-2019 by Total Value Received
The biopharma industry saw a significant increase in the number of deal terminations in the last two years. Clinical and regulatory results- change in control limitations- and strategic reprioritizations were among the most common reasons for deal termination. We used the DealForma database to track partnership terminations announced in 2018 and 2019. We compiled a list of…
January 3, 2020
Biosimilar Companies Top 20 2018
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
​ Biosimilars are the key alternatives for expensive Biologics therapies and saving millions of dollars of patients spent in the treatment of multiple diseases. Hence physicians are likely to adopt biosimilars a reference product to biologics possessing similar therapeutic properties in terms of potency- safety- and efficacy to original biologic products. The companies are focusing…
November 29, 2019
Biopharma Acquisitions Top 20 2018
Top 20 Biopharma Acquisitions of 2018 Based on the Total Deal Value
Biopharma acquisition activity in 2018 shows a significant increase over the previous year. Takeda proved to be on top with the acquisition of Shire among the top 20 acquisitions with a total deal value of $57.17B strengthening its capabilities in gastroenterology- neuroscience- oncology- rare diseases- and plasma-derived therapies. This article is based on the 2018…
September 27, 2019
Generics Pharma Companies Top 20 2018
Top 20 Generics Pharma Companies Based On 2018 Revenue
The global generics pharmaceutical market is continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs- are always needed in the market. Generics are approved copies of small molecule drugs which contain the same amount of active ingredients- dosage form- safety- strength- route of administration- quality- performance characteristics- as of…
September 13, 2019
Life Sciences Deals Top 20 2018
Top 20 Life Sciences Deals of 2018 Based on Total Deal Value
Healthcare- pharmaceutical- and biotech companies are gearing up to tap new markets as they look to consolidate their positions after a spate of mergers & acquisitions and licensing partnerships in 2018. The highest valued deal proved to be of Takeda's acquisition of Shire for $57B with the focus on global R&D- its robust and modality-diverse…
August 23, 2019
Immunology Companies Based Top 20 2018
Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue
The increasing cases of autoimmune disorders such as rheumatoid arthritis are driving the growth of immunology products in the global market. Multiple companies have been focusing on Oncology- Hematology and multiple diseases but due to a drastic increase in the immune disorders- Immunology segment has been widely spared across the globe. In the top 20…
August 9, 2019
Diagnostics Companies Based Top 20 2018
Top 20 Diagnostics Companies Based On 2018 Revenue
With the era of growing diseases- Diagnostics have played a vital role in diagnosing multiple diseases and disorders. The healthcare system is changing- with a greater focus on value- reducing errors and giving more cost-effective care and treatments. The Diagnostic ledger has not changed much in comparison to 2017. Roche Diagnostics holds to be at…
July 19, 2019
Medical Device Companies Based Top 20 2018
Top 20 Medical Device Companies Based on 2018 Revenue
The Medical device market is growing with greater needs of patients and with their emerging diseases. 2018 has shown major advancement in medical device needs and upgrades with 55 novel drug approvals. The year 2018 has shown a slight change in the ledger of top 20 firms while Medtronic holds its first position with a…
June 6, 2019
Oncology Companies Top 10 2018
Top 10 Oncology Companies By 2018 Revenue
The Pharma companies focusing on oncology has been emerging in market with greater needs of people suffering from Cancer. The sales of oncology drugs gradually increasing with diseases. The top oncology companies are now developing more advanced- effective- and tolerable drugs to improve treatment outcomes and the patient experience. Roche proved to be on top…
May 31, 2019
BioPharma Companies based Top 20 2018
Top 20 BioPharma Companies based on 2018 Total Revenue
The global pharma companies have been advancing their pipelines with emerging needs of patients. Pharma companies are also focusing on diagnostics & devices- which were emerged as one of major revenue generator in 2018- with the development of new products and devices. The year 2018 also proved to be a record with approval of 55…
May 1, 2019